
- November 2014 Cough & Cold
- Volume 80
- Issue 11
Kids Infected with H1N1 More Susceptible to Severe Complications
Children infected with the H1N1 influenza strain may be more likely to develop serious complications than children infected with other flu strains, the results from a recent study suggest.
The study, published in the September 2014 issue of Pediatrics, analyzed the development of severe complications among children 19 years and younger presenting to the emergency department for moderate to severe influenza-like illness during peak respiratory viral seasons from 2008 to 2010. Severe complications included respiratory failure, encephalopathy, seizures, pneumonia, bacteremia, and death. Information on demographics, comorbidities, and household exposures were collected to determine risk factors for complications.
Overall, 35.3% of the children included in the study developed severe complications. Those with neurologic or neuromuscular conditions had an increased risk for these complications. The risk for complications did not significantly differ by infecting virus; however, risks differed for flu subtypes. Among children with influenza, those infected with the H1N1 strain were at the highest risk for developing all severe complications and for pneumonia.
Articles in this issue
almost 11 years ago
Confronting the Challenge of Health Care-Associated Infectionsalmost 11 years ago
Whooping Cough Still Common Among Kids with Persistent Coughalmost 11 years ago
Immune Response to Flu Increases During Pregnancyalmost 11 years ago
Online System Could Prevent Disease Spread in Preschoolsalmost 11 years ago
Antimicrobials Prescribed Often for Respiratory Infectionsalmost 11 years ago
Colds Identified as Risk Factor for Stroke in Kidsalmost 11 years ago
Cigarette Purchases Commonly Accompany Asthma Prescription Refillsalmost 11 years ago
Physician-Pharmacist Collaboration Keeps Asthma Patients Out of HospitalsNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.















































































































































































































